Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Neuroradiological evaluation of demyelinating disease.
Central nervous system demyelinating disease-associated uveitis.
Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis.
[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]
A mechanism-based classification of pain in multiple sclerosis.
Tetrahydrocannabinol
CUPID: Cannabinoid Use in Progressive Inflammatory brain Disease
Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.
Histological characterization and quantification of cellular events following neural and fibroblast(-like) stem cell grafting in healthy and demyelinated CNS tissue.
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function.
Cognitive impairment in patients with multiple sclerosis predicts worse caregiver's health-related quality of life.
In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients.
Targeting CXCL13 During Neuroinflammation.
[Diagnosis and treatment of pelvic disorders in patients with multiple sclerosis].
New Data Show Longer Tysabri Dosing Interval in MS Is Feasible
Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance.
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients.
Aging and multiple sclerosis.
Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.
Usability and Potential of Geostatistics for Spatial Discrimination of Multiple Sclerosis Lesion Patterns.
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
Liposome-encapsulated peptides protect against experimental allergic encephalitis.
Bouncing back again, and again: a qualitative study of resilience in people with multiple sclerosis.
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.

Pages